ABSTRACT BACKGROUND There is considerable overlap between left ventricular noncompaction (LVNC) and other
L eft ventricular noncompaction (LVNC) is
characterized as a primary genetic cardiomyopathy by the American Heart Association, but is characterized by the European Society of Cardiologists as an "unclassified cardiomyopathy," aptly demonstrating some of the controversy that surrounds this condition (1) (2) (3) . Previously considered a rare cardiomyopathy, there has been a rapid proliferation in publications regarding this entity, raising the question of whether this is a result of better identification of those with the disease or whether it is being overdiagnosed due to the rapid expansion in the utilization of cardiac imaging and the everimproving visualization of cardiac structures (4, 5) . More than 8% of athletes meet 1 of the 3 current echocardiographic criteria for LVNC, whereas 43% of a healthy population cohort meet the most commonly used cardiac magnetic resonance imaging (CMR) threshold for diagnosis measured on long axis cine sequences as proposed by Peterson et al. (6) (7) (8) .
In addition, a high prevalence of LVNC has been observed in both dilated and hypertrophic cardiomyopathies (9, 10) .
Since the original CMR criteria was proposed by Petersen et al. (7) , several other groups have developed alternate diagnostic criteria with improved sensitivity and specificity, utilizing measurements on both short axis systolic and diastolic views of the left ventricle as well as quantifying the compacted-tononcompacted myocardial mass ratio (11) (12) (13) . However, given the earlier findings from multiple studies utilizing multiple imaging modalities of significant noncompaction in asymptomatic cohorts free from known cardiovascular disease (CVD), it is not clear whether these new criteria help identify those with genuine disease, or whether, when applied to the general population, they will serve to further strengthen the notion of LVNC as an anatomical phenotype rather than a pathological entity. This is of significant clinical importance due to the long-term implications that currently receiving a diagnosis of LVNC entails-impacting insurance costs and necessitating long-term monitoring and follow-up. The aim of this study was to determine the prevalence of the population exhibiting LVNC, the predictors for the presence LVNC, and the physiological implications of noncompaction on cardiac function. 3) had a serum B-type natriuretic peptide (BNP) level greater than their gender specific median; and 4) had a 10-year risk of coronary heart disease <20% as predicted by the Adult Treatment Panel III algorithm (14) .
Exclusion criteria included the following: 1) pregnancy; 2) known primary muscle disease; 3) known atherosclerotic disease-including angina, previous myocardial infarction, peripheral arterial disease, amputation, previous revascularization surgery, hypertension, heart failure, or cerebrovascular event; 4) known diabetes; 5) active liver disease; 6) other known illness or contraindication to magnetic resonance imaging (MRI); 7) participation in another clinical trial; 8) inability to give informed consent; 9) known alcohol abuse; and 10) a blood pressure >145/ 95 mm Hg. Details of the TASCFORCE study arms and design are encapsulated within Figure 1 .
IMAGE ACQUISITION. The MRI protocol has been described in detail elsewhere (15) . In brief, imaging was performed using a 3-T Magnetom Trio Scanner (Siemens, Erlangen, Germany). Whole-body magnetic resonance angiography was performed using a dualbolus injection technique with the CMR cines performed before the first contrast injection, and the late gadolinium enhancement sequences performed between the first and second contrast bolus injections.
For CMR, a body matrix radiofrequency coil (6 elements) was used in combination with a spine array (up to 24 elements). IMAGE ANALYSIS. LV mass and volume quantification was performed as previously described (15) .
Values were normalized to height 1.7 . For noncompaction assessment, each of the 4 diagnostic criteria was measured as follows (Central Illustration): 2. Short axis noncompaction (SAX) was performed using the short axis cine images, with the region of highest noncompacted myocardium to compacted myocardium ratio measured both in diastole and systole, as described by Stacey et al. (12) and Grothoff et al. (13 Those who met all 4 diagnostic criteria for LVNC were taken as demonstrating the LVNC phenotype. Values are n (%). used. This suggests that LAX noncompaction is not only the least specific criterion (resulting in the most over diagnosis) in our study cohort, but also has limited implications for LV remodeling.
The observation of high incidence of LVNC in 2 separate population studies indicates 1 of 2 possibilities. One is that the current diagnostic criteria lack specificity for the accurate identification and diagnosis of LVNC, with resultant extensive over diagnosis in normal individuals. Indeed, the poor correlation between the measures, with 15% of the study cohort meeting at least 1 criterion but <2% meeting all 4, suggest that the feature they are measuring is poorly captured by any 1 of the techniques. This is in keeping with previous observations using echocardiographic diagnostic criteria in which, in a population with known heart failure and diagnosis of LVNC, only 29.8% met all 3 criteria, whereas 36.3% fulfilled only 1 criterion (19) . In the current study we have not assessed the use of fractal analysis, Tables 2 and 3 . 
